AMANDA REID: Open Payments
NPI 1003376609 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 63 payments from 12 companies in 2025. Trend: 2023 $457 · 2024 $787 · 2025 $1,400
Food & beverage: $1,397Education: $3
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $304 |
| Regeneron Healthcare Solutions, Inc. | 11 | $269 |
| GlaxoSmithKline, LLC. | 17 | $268 |
| GENZYME CORPORATION | 8 | $212 |
| CSL Behring | 5 | $89 |
| Amgen Inc. | 4 | $81 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| LEO Pharma Inc. | 1 | $22 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, TRELEGY ELLIPTA, Hizentra, NEFFY, AYVAKIT, Xolair.
Industry payments across KY — which companies pay providers there.
